This post is from a suggested group
Revolutionizing Treatment: The Growth of the Genomics In Cancer Care Market
Description The Genomics In Cancer Care Market is transforming oncology by leveraging advanced sequencing technologies and personalized medicine to improve diagnosis, tailor treatment plans, and enhance patient outcomes across various cancer types.
The Genomics In Cancer Care Market is experiencing dynamic and high-value growth, projected to reach an estimated $190.88 billion by 2034, expanding at a robust CAGR of 15.14%. This growth is a direct result of two primary factors: the increasing global cancer burden and continuous, rapid advancements in genomic sequencing technologies, such as Next-Generation Sequencing (NGS). NGS has drastically lowered the cost and time of genetic profiling, making genomic analysis a more routine and accessible part of clinical oncology.
Genomics has applications spanning the entire cancer journey, from early detection through diagnosis and monitoring. Diagnostic Testing currently holds the largest revenue share, though Prognostic Testing is expected to…